Genes to be ’flipped’ for drug-free treatment
The body’s own defences could be programmed to attack disease to order if two University of Leeds’ scientists succeed in proving their innovative theory.
Dr Graham Cook and Dr Erica de Wynter from the Molecular Medicine Unit have secured £125,000 to investigate the unique way antibody genes are assembled and how they can be harnessed to fight disease.
Scientists don’t often get funding for research where there is no preliminary data or background information but the pair have been funded by the Wellcome Trust’s Showcase scheme to research new ways to repair damaged immune systems.
Their research into ‘flipping genes therapy’ met the Trust’s criterion of being ‘speculative, novel, adventurous, innovative’.
Dr Cook said antibodies can be made to respond to every kind of pathogen. “Antibodies are created by taking bits of genes and reassembling them into different combinations, like a giant Lego set. If we can understand the mechanism by which genes are ‘flipped’ in this way, we can insert genes for the body to naturally rearrange, delivering treatments directly to the immune system.”
If their idea works, it could open the door to new therapies for treating immune-deficiency disorders and even provide a treatment for cancers of the immune system, by adding genes to make the cancerous cells die.
“The benefit of this kind of treatment is that it would use the cell’s natural mechanism to help fight disease,” said Dr de Wynter. “Our body uses this system to produce diversity, an insurance system against the ever changing pathogens it has to fight. Our problem is we want to specify the mechanism to create just one antibody, and while we believe it can work, we’ve now got to prove it. We think we can prove our idea is possible in the next two years.”
All latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Breakthrough brings potential glioblastoma drug into focus
A new class of small molecule drugs, now in phase 1 clinical trials, is the first to target circadian clock proteins, which play a key role in the recurrence and…
Powerful Bragg reflector with ultrahigh refractive index metamaterial
We all look in the mirror at least once a day to see our reflection. Mirrors are used not only in daily life but also in cutting-edge technologies such as…
Casting shadows on solar cells connected in series
In shaded conditions, photovoltaics linked end-to-end experience more power loss than cells running in parallel. Large obstacles, like clouds and buildings, can block sunlight from reaching solar cells, but smaller…